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CASE REPORT
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Summary
Introduction: Tongue metastasis of renal cell carcinoma (RCC) is rare. Treatment is hindered
by the proximity of anatomic structures involved in swallowing, speech and mastication. It is,
moreover, radioresistant.
Case report: We report a case of inaugural isolated tongue metastasis, where biopsy redirected
diagnosis to RCC. To avoid potentially mutilating excision in a metastatic disease of poor progno-
sis, treatment was local, consisting in interstitial brachytherapy, enabling a high dose (65Gy) to
be delivered. Despite initially complete response, recurrence at 10.5months required salvage
surgery.
Discussion and conclusion: Brachytherapy allowed a higher dose to be delivered than with exter-
nal beam radiation therapy, previously reported for similar cases. This dose, which can usually
be expected to ensure local control in 90% of squamous cell carcinomas of the tongue, obtained
10months’ response, insufﬁcient to avoid salvage surgery.
© 2013 Elsevier Masson SAS. All rights reserved.
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(Introduction
Renal cell carcinoma (RCC) is the urologic cancer with the
3rd highest incidence in men, after prostate and colorec-
tal cancer. Metastasis is most frequently to the lungs, bone
or liver, but is notorious for also involving any other body
region. Tongue metastasis is extremely rare, but difﬁcult to
manage in light of the generally poor prognosis associated
with metastatic RCC and of the functional importance of the
tongue.
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66-year-old man, with no particular history except moder-
te smoking and controlled high blood pressure, consulted
or a persistent tongue lesion. The lesion was medially
ocated and exophytic, covering the dorsal side of the tongue
Fig. 1A). Biopsy unexpectedly indicated high grade RCC
Fig. 2). Abdominal CT was therefore performed, and found
mass at the superior end of the left kidney (Fig. 3).
xtension assessment found no further locations. Extended
ephrectomy conﬁrmed diagnosis, and systemic sunitinib
herapy was initiated. Six months later, the lesion measured
2mm on the long axis, with maximal lingual inﬁltration of
0mm (Fig. 1B). Given the poor prognosis associated with
etastatic RCC and with the surgical resection that would
e required, local conservative treatment by interstitial
served.
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Figure 1 Photographs of the tongue lesion. A. At diagnosis. B. After 6months’ sunitinib treatment. C. 6weeks after brachytherapy.
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ﬁve other cases; and, in contrast to the great majority ofigure 2 Histologic cross-section of the tongue lesion, which
edirected diagnosis to renal cell carcinoma (RCC) metastasis.
rachytherapy was implemented. Three parallel loops were
ositioned in the sagittal plane under general anesthesia,
nd a dose of 65Gy was delivered by iridium 192wires over a
eriod of 6 days 3 hours (low dose rate, 44 cGy/h) (Fig. 4). Six
eeks post-treatment, the lesion showed complete response
Fig. 1C).
One year post-diagnosis, control CT found recurrence
ithin the nephrectomy cavity, conﬁrmed histologically and
reated by radiofrequency ablation. Extension assessment
ound further small locations, and sunitinib was therefore
eplaced by everolimus, an mTOR inhibitor. Ten months post-
rachytherapy, bleeding led to diagnosis of recurrent tongue
etastasis. Despite chemotherapy with dovinitib (a vascu-
ar endothelial growth factor [VEGF] and ﬁbroblast growth
actor [FGF] receptor inhibitor), the lesion progressed over
he posterior two-thirds of the mobile tongue and ante-
ior third of the tongue base, extending well over the
edian line, impairing swallowing although mobility was
onserved, as were the epiglottic valleculae. A little over
years post-diagnosis, left partial glossectomy was per-
ormed with ipsilateral selective lymph-node resection and
econstruction by free anterolateral thigh ﬂap. Histologic
nalysis of the surgical specimens found a 65× 45× 20mm
p
t
ligure 3 Axial abdominal CT slice showing primitive left renal
esion.
esion, completely resected, without lymph-node inﬁltra-
ion. Three months postoperatively, despite good local
volution, reassessment found progression of the visceral
esions, leading to death 5months following the glossec-
omy.
iscussion
ongue metastases of solid cancers are rare, at 0.2% in a
eries of 6881 autopsies, 99% of which concerned cancer
atients; none of the 12 cases analyzed concerned renal
ancer, and only four had shown functional signs ahead of
eath [1]. Onset of functional signs is late in renal cancer,
nd almost one-third of patients have metastases at diagno-
is. ENT metastases are estimated at 15%, mainly involving
he sinuses, larynx, parotid glands and cranial bone. Lingual
etastasis is exceptional [2—4]; a recent literature review
etrieved 28 cases [5]. The present report is original in two
ays: the tongue metastasis was inaugural, reported in onlyrevious reports, it was isolated. In Tomita et al.’s report,
ongue metastasis was synchronous with other secondary
ocations in 83.3% of cases [6]; prognosis was poor, 12 of their
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[Figure 4 Orthogonal X-ray views
18 patients having died within 1 year of diagnosis (although it
is to be borne in mind that these ﬁndings predate the intro-
duction of antiangiogenics in the management of metastatic
RCC) [6,7].
Regarding management of tongue metastasis, most clin-
ical reports are of surgical resection, as this type of tumor
is notoriously radioresistant. Radiation therapy is gener-
ally a complement to marginal, insufﬁcient or palliative
resection. Doses thus range from 30 to 60Gy, with no
standard protocol emerging. Local recurrence was reported
4months after completion of exclusive 50Gy radiation ther-
apy [6]. In the present case, brachytherapy was chosen in
the light of experience with squamous cell carcinoma of the
tongue. The technique limits the target volume as compared
to external beam radiation, better protecting the organs
involved in speech, salivation, swallowing and mastication.
The radioactive sources are in direct contact with the lesion,
in the tongue, enabling a higher dose and circumventing the
problems of tongue movement. A dose of 65Gy could thus
be applied, higher than hitherto reported; even so, local
control was maintained for only 10months, whereas such a
dose could be expected to achieve around 90% local control
in squamous cell carcinoma of the tongue of a similar size
[8].
ConclusionTongue metastasis of RCC is rare and difﬁcult to
treat locally. Conservative management by brachyther-
apy provided 10months’ response, insufﬁcient to avoid
surgery.
[plantation (A. Frontal. B. Lateral).
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